LifeScan to pay $45 million to settle lawsuit:
This article was originally published in Clinica
Executive Summary
Johnson & Johnson's LifeScan subsidiary has agreed to pay $45 million to diabetics to settle a class action suit claiming its products were defective. The settlement applies to as many as 400,000 diabetics who bought the device before August 1997, when the problems were solved. Late last year, the company paid $60 million after pleading guilty to misdemeanour charges relating to the SureStep blood glucose meter (see Clinica No 940, p 11).